Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2022 - 07 - 12    symbols : Sny    save search

Patients with Lupus Benefit from COVID-19 Vaccine Booster
Published: 2022-07-12 (Crawled : 23:00) - prnewswire.com
SNYNF | $92.966 0.07% -2.18% 630 twitter stocktwits trandingview |
Health Technology
| | O: -0.1% H: 0.0% C: -2.06%
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.37% H: 0.38% C: -0.13%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -1.38% H: 0.0% C: 0.0%

covid-19 vaccine lupus
Knopp, Population Health Launch Areteia to Breathe New Life into Old Molecule
Published: 2022-07-12 (Crawled : 19:00) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

health life
Worldwide Bladder Cancer Drugs Market to Reach $4.45 Billion in 2026 at a CAGR of 17.3%
Published: 2022-07-12 (Crawled : 18:00) - prnewswire.com
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%
AMGN | $265.51 -0.66% -0.67% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.93% C: -0.33%
ADAP | $1.05 -9.48% -8.92% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.53% C: 2.92%

bladder cancer market drug
Moderna mRNA Portfolio on Track to Hit 2025 Goal with Nipah Virus Trial Launch
Published: 2022-07-12 (Crawled : 17:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

mrna virus trial
Moderna on Track to Hit 2025 Goal with Launch of Nipah Virus Trial
Published: 2022-07-12 (Crawled : 16:00) - biospace.com/
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

virus trial
$350M Funding Breaths New Life into Former ALS Compound for Asthma
Published: 2022-07-12 (Crawled : 15:20) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

life als funding
VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer
Published: 2022-07-12 (Crawled : 13:00) - biospace.com/
VBIV | $0.58 -3.39% 250K twitter stocktwits trandingview |
Health Technology
| | O: 1.27% H: 6.58% C: 4.65%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

commercial vaccine
Spotlight Therapeutics Appoints Visionary Global Pharma Drug Developer Antoine Yver, M.D., M.Sc. as First Independent Board Member
Published: 2022-07-12 (Crawled : 12:20) - biospace.com/
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

pharma drug therapeutics
Knopp Biosciences and Population Health Partners Create Areteia Therapeutics, New Clinical-Stage Asthma Company, with $350 Million in Funding
Published: 2022-07-12 (Crawled : 12:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: 1.87% H: 0.0% C: -3.01%
JNJ | $147.59 0.05% -0.18% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
GSK | $40.5 -0.39% -1.09% 2.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.28% H: 0.12% C: -1.68%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

health funding
Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037
Published: 2022-07-12 (Crawled : 11:00) - prnewswire.com
BMY | $48.51 0.48% -0.02% 9.8M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.7% C: -0.56%
ABT | $108.89 -0.2% 0.0% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.72% C: -0.18%
SNY | $46.24 0.68% 0.63% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.0% C: 0.0%

expected cancer market
Gainers vs Losers
46% 54%

Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M twitter stocktwits trandingview |
Wholesale Trade

PXMD | $0.74 79.7% 44.16% 4.5M twitter stocktwits trandingview |
Health Technology

DYNT | $0.3704 -5.27% 43.09% 1.6M twitter stocktwits trandingview |
Health Technology

LGVN P 3 d | $2.93 73.37% 42.52% 56M twitter stocktwits trandingview |

HUBC | $1.95 50.0% 32.99% 73M twitter stocktwits trandingview |
n/a

SPCB | $0.4004 45.07% 31.75% 130M twitter stocktwits trandingview |
Electronic Technology

ONVO | $1.35 33.65% 24.62% 53M twitter stocktwits trandingview |
Health Technology

OMQS | $0.7038 35.35% 24.3% 3.5M twitter stocktwits trandingview |
Professional, Scientific, and T...

SNPO | $10.54 29.48% 22.88% 3.9M twitter stocktwits trandingview |

EEIQ | $1.16 27.46% 20.86% 6.9K twitter stocktwits trandingview |
Educational Services


Your saved searches
Save your searches and get alerts when important news are released.